1. Ebola Vaccine Saves Lives Even After Exposure.
- Author
-
Eppinger, Ute
- Subjects
EBOLA virus disease ,EBOLA virus ,VACCINES ,VACCINE effectiveness ,HEALTH facilities - Abstract
A study published in The Lancet Infectious Diseases has found that the Ervebo vaccine, approved for use against Zaire ebolavirus, not only reduces the risk of Ebola infection but also halves mortality rates. The study analyzed data from the 10th Ebola epidemic in the Democratic Republic of the Congo and found that the mortality risk was 56% for unvaccinated patients and only 25% for vaccinated patients. The vaccine is primarily recommended for ring vaccination of individuals at high risk for infection during an epidemic and has a preliminary estimated effectiveness of 97.5%-100% 10 days after vaccination. The study also found that the vaccine still provides significant protection against death even when administered after exposure to the virus. [Extracted from the article]
- Published
- 2024